CINECA IRIS Institutional Research Information System

FORNI, Guido
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.274
EU - Europa 5.086
AS - Asia 4.427
SA - Sud America 697
AF - Africa 140
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 17.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.072
SG - Singapore 1.939
CN - Cina 1.379
IT - Italia 744
UA - Ucraina 667
DE - Germania 637
IE - Irlanda 594
SE - Svezia 591
BR - Brasile 580
FR - Francia 508
FI - Finlandia 440
KR - Corea 440
VN - Vietnam 308
GB - Regno Unito 285
PL - Polonia 164
CA - Canada 159
AT - Austria 133
DK - Danimarca 125
HK - Hong Kong 73
IN - India 68
SN - Senegal 66
NL - Olanda 51
AR - Argentina 43
RU - Federazione Russa 38
ID - Indonesia 32
MX - Messico 30
BE - Belgio 28
EC - Ecuador 25
JP - Giappone 24
ZA - Sudafrica 23
IQ - Iraq 22
BD - Bangladesh 19
UZ - Uzbekistan 19
IL - Israele 14
CO - Colombia 13
ES - Italia 13
IR - Iran 10
LT - Lituania 10
SA - Arabia Saudita 10
TR - Turchia 10
TW - Taiwan 10
CH - Svizzera 9
PY - Paraguay 9
VE - Venezuela 9
GR - Grecia 8
MA - Marocco 8
PH - Filippine 8
DZ - Algeria 7
MU - Mauritius 7
UY - Uruguay 7
AL - Albania 6
CZ - Repubblica Ceca 6
EG - Egitto 6
PT - Portogallo 6
AU - Australia 5
EU - Europa 5
KE - Kenya 5
KZ - Kazakistan 5
PE - Perù 5
RO - Romania 5
BG - Bulgaria 4
CL - Cile 4
JO - Giordania 4
LB - Libano 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
GA - Gabon 3
KG - Kirghizistan 3
PK - Pakistan 3
TN - Tunisia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HU - Ungheria 2
MN - Mongolia 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
TG - Togo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BN - Brunei Darussalam 1
CD - Congo 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 17.625
Salva come PNG Salva come JPEG
Città #
Beijing 967
Singapore 945
Chandler 940
Dublin 594
Jacksonville 430
Ashburn 424
Ann Arbor 362
Villeurbanne 327
Houston 324
Santa Clara 247
Medford 232
Princeton 222
Columbus 184
Dearborn 183
Nyköping 178
Buffalo 163
Warsaw 158
Los Angeles 155
Wilmington 154
Vienna 125
Torino 123
The Dalles 114
Dallas 110
Munich 103
Milan 99
Hefei 85
Toronto 84
Fremont 81
Fairfield 79
Boston 75
Seoul 75
Dong Ket 66
Hong Kong 66
Hanoi 65
Ho Chi Minh City 63
Woodbridge 63
Boardman 55
Verona 54
New York 52
São Paulo 47
Turin 47
Seattle 43
Pisa 38
Rome 38
Falls Church 32
Cambridge 28
Guangzhou 28
Norwalk 28
Brussels 26
Ottawa 26
Lachine 25
Turku 25
Washington 24
Pune 23
Düsseldorf 21
Helsinki 19
Nanjing 19
Jakarta 18
Tokyo 18
Nuremberg 17
Rio de Janeiro 17
Frankfurt am Main 16
Amsterdam 15
Kunming 14
Phoenix 14
Redwood City 14
Mountain View 13
Redondo Beach 13
Belo Horizonte 12
Chennai 12
Montreal 12
Brooklyn 11
Des Moines 11
Haiphong 11
Jinan 11
Regensburg 11
Stockholm 11
Baghdad 10
Chicago 10
San Francisco 10
Shanghai 10
Biên Hòa 9
Curitiba 9
Johannesburg 9
Quito 9
Tashkent 9
Athens 8
Atlanta 8
Guayaquil 8
Nürnberg 8
Padova 8
Philadelphia 8
Redmond 8
San Diego 8
Camerino 7
Campinas 7
Cape Town 7
Detroit 7
Dhaka 7
Hải Dương 7
Totale 9.825
Salva come PNG Salva come JPEG
Nome #
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 474
Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development 293
Regulation of expression of PI3Kbeta protein in tumors 286
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 254
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 247
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters 222
Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice 191
Effective anti-tumor immunomodulatory properties of zoledronic acid 171
Activation of T cells against HER-2/neu+ by autologous dendritic cells loaded with rat HER-2/neu+ cells in the presence of CCL16 170
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 162
Zoledronic acid repolarizes tumor-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway 157
Activation of T cells against human HER-2/neu by autologous Dendritic Cells loaded with rat HER-2/neu+ cells in the presence of CCL16 154
Adriamycin-induced proteinuria in nude mice: an immune-system-mediated toxic effect. 145
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions 143
p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity 142
Vaccination to kitL: a new approach to inhibit tumor angiogenesis 142
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins 140
5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. 139
2011: the immune hallmarks of cancer. 139
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity 137
Immunological inhibition of carcinogenesis 137
Immunotherapy and immunoprevention of cancer: where do we stand? 133
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 132
DNA vaccination against Her-2 by electroporation protects rodents against squamous cell carcinomas 131
Paramagnetic metal complexes for the MRI visualization of internalized polynucleotides 131
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice 131
A role for WASP Interacting Protein, WIP, in fibroblast adhesion, spreading and migration 130
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy. 129
A better immune reaction to Erbb-2 129
Cure of Mammary Carcinomas in Her-2 Transgenic Mice Through Sequential Stimulation of Innate (neo-adjuvant IL12) and Adaptive (DNA Vaccine Electroporation) Immunity 129
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention 129
Erbb2 DNA vaccine combined with Treg cell deletion enhances antibody response and reveals latent low-avidity T cells. Potential and limits of its therapeutic efficacy. 127
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 124
Le difese immunitarie. 123
Human lung carcinoma cells engineered to release IL2, IL7, GM-CSF and TNF alpha 123
Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice 122
A new optical imaging probe targeting α(V) β(3) integrin in glioblastoma xenografts. 122
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. 121
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination 120
p130Cas is an essential transducer element in ErbB2 transformation 118
Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx 116
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 116
A tumour-associated membrane antigen transiently expressed by normal cells during mitosis. 115
Distribution of interferon-gamma receptor in human tissues. 115
Anaplastic Lymphoma Kinase is an effective oncoantigen for lymphoma vaccination 115
Anti-HER-2 DNA vaccine protects Syrian hamsters against squamous cell carcinomas 115
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene 115
Visualization through magnetic resonance imaging of DNA internalized following "in vivo" electroporation 114
Human lymphocyte activation requires IFN-γ-mediated signals. 113
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. 113
Lactoferrin, a Major Defense Protein of innate immunity, is a novel maturation factor for human dendritic cells 113
Cytokine-induced tumor immunogenicity: from exogenous cytokines to gene therapy 110
A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles (VLPs) prevents outgrowth of Her2/neu expressing tumors 109
p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene–dependent breast tumorigenesis 109
Antitumor vaccines genetically engineered with cytokine gens 109
DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer prone transgenic mice 108
DNA Vaccines Targeting Tumor Antigens to B7 Molecules on Antigen-Presenting Cells Induce Protective Antitumor Immunity and Delay Onset of HER-2/Neu-Driven Mammary Carcinoma 108
Effective anti-tumor immunomodulatory properties of zoledronic acid in Balb/c mice transgenic for the her-2/Neu oncogene 106
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 106
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis 106
p185neu-Encoding DNA and therapeutical uses thereof 105
Dendritic cells transfected with DNA encoding ErbB2 rat/human chimeric plasmids are able to activate in vitro a specific T cell response in ErbB2+ cancer patients 104
Zoledronic acid impairs mammary carcinogenesis in BALB/c mice transgenic for the Her-2/neu oncogene. 104
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth 103
Valutazione preclinica di un nuovo approccio terapeutico: la vaccinazione a DNA protegge dal carcinoma sqaumoso orale chimicamente indotto 103
DNA vaccination against ERBB2 oncoantigen impairs oral tumor development 102
Immune recognition of tumor cells in vivo. I. Role of H-2 gene products in T lymphocyte activation against minor histocompatibility antigens displayed by adenocarcinoma cells. 101
Towards a long-lasting immune prevention of HER2 mammary carcinomas: directions from transgenic mice 101
COSTRUTTO DI ACIDO NUCLEICO, VETTORE E VACCINO A DNA INCLUDENTI DETTO COSTRUTTO 101
DNA codificante forme tronche e chimeriche della proteina p185neu e suoi usi terapeutici 101
A 'stealth effect': adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 99
Antiblastic chemotherapy drugs up-modulate interferon-gamma receptor expression on human malignant T cells 99
CCL16 enhances the CD8+ and CD4+ T cell reactivity to human HER-2 elicited by dendritic cells loaded with rat ortholog HER-2 98
Negative cell cycle control of human T cells by beta-galactoside binding protein (beta GBP): induction of programmed cell death in leukaemic cells. 97
Adenovirus vaccination against neu oncogene exerts long-term protection from tumorigenesis in BALB/neuT transgenic mice 96
Beta-galactoside-binding protein (beta GBP) alters the cell cycle, up-regulates expression of the alpha- and beta-chains of the IFN-gamma receptor, and triggers IFN-gamma-mediated apoptosis of activated human T lymphocytes 96
Immunization in tumor prevention. 95
Intramammary Application of Non-Methylated-CpG Oligodeoxynucleotides (CpG) Inhibits both Local and Systemic Mammary Carcinogenesis in Female BALB/c Her-2/neu Transgenic Mice 94
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 93
Treatment of oral cavity and oropharynx squamous cell carcinoma with perilymphatic interleukin-2: clinical and pathologic correlations. 91
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 91
Effect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts. 90
Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice 90
Regulation of interferon-gamma receptor (INF-gammaR) chains: a peculiar way to rule the life and death of human lymphocytes. 90
Therapeutic vaccination halts disease progression in BALB-neuT mice: the amplitude of elicited immune response is predictive of vaccine efficacy 90
Molecular approaches to cancer immunotherapy. 89
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. 89
Evidence for a membrane carrier molecule common to embryonal and tumour-specific antigenic determinants expressed by a mouse transplantable tumour. 88
Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. 88
L'INTERAZIONE TRA INTERFERONE GAMMA E IL SUO RECETTORE COSTITUISCE UN SEGNALE AUTOCRINO INDISPENSABILE PER L'INDUZIONE DELLA RISPOSTA IMMUNITARIA 88
Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe bindingαvβ3integrins 87
Distinct and non-overlapping T cell receptor repertoires expanded by DNA vaccination in wild-type and HER-2 transgenic BALB/c mice 85
TUMORI 85
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 84
Are oncoantigens suitable targets for anti-tumour therapy? 83
Blockade of physiologically secreted IFN-gamma inhibits human T lymphocyte and natural killer cell activation. 80
In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probes 79
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. 79
Molecular basis of the immunogenicity of cell surface tumor antigens. 78
Requirement for IFN-gamma, CD8+ T lymphocytes, and NKT cells in talactoferrin-induced inhibition of neu+ tumors 78
Totale 12.374
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.063
article - articoli 0
book - libri 0
conference - conferenze 5.506
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.569
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021797 0 0 0 0 0 40 139 30 241 107 86 154
2021/20221.514 33 35 46 108 60 38 148 78 65 125 304 474
2022/20232.662 305 180 35 285 259 731 194 165 300 54 104 50
2023/2024858 133 155 50 32 46 151 28 36 0 20 56 151
2024/20252.697 19 141 58 305 608 120 71 132 380 202 213 448
2025/20262.985 542 304 475 858 684 122 0 0 0 0 0 0
Totale 18.195